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Abstract
Recent advances have made it possible to readily derive cardiac myocytes from human
induced pluripotent stem cells (hiPSC-CMs). HiPSC-CMs represent a valuable new experi-
mental model for studying human cardiac muscle physiology and disease. Many laborato-
ries have devoted substantial effort to examining the functional properties of isolated hiPSC-
CMs, but to date, force production has not been adequately characterized. Here, we utilized
traction force microscopy (TFM) with micro-patterning cell printing to investigate the maxi-
mum force production of isolated single hiPSC-CMs under varied culture and assay condi-
tions. We examined the role of length of differentiation in culture and the effects of varied
extracellular calcium concentration in the culture media on the maturation of hiPSC-CMs.
Results show that hiPSC-CMs developing in culture for two weeks produced significantly
less force than cells cultured from one to three months, with hiPSC-CMs cultured for three
months resembling the cell morphology and function of neonatal rat ventricular myocytes in
terms of size, dimensions, and force production. Furthermore, hiPSC-CMs cultured long
term in conditions of physiologic calcium concentrations were larger and produced more
force than hiPSC-CMs cultured in standard media with sub-physiological calcium. We also
examined relationships between cell morphology, substrate stiffness and force production.
Results showed a significant relationship between cell area and force. Implementing
directed modifications of substrate stiffness, by varying stiffness from embryonic-like to
adult myocardium-like, hiPSC-CMs produced maximal forces on substrates with a lower
modulus and significantly less force when assayed on increasingly stiff adult myocardium-
like substrates. Calculated strain energy measurements paralleled these findings. Collec-
tively, these findings further establish single cell TFM as a valuable approach to illuminate
the quantitative physiological maturation of force in hiPSC-CMs.
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Introduction
Over the past several years it has become possible to efficiently derive robust, spontaneously
contracting cardiac myocytes (hiPSC-CMs) from human induced pluripotent stem cells
(hiPSCs)[1, 2, 3]. Regarded as a viable source of virtually unlimited human cardiac muscle tis-
sue, researchers and clinicians have begun utilizing hiPSC-CMs as potential source for thera-
peutic cell-based repair via transplantation into host[4] and for cellular and tissue models of
cardiac disease[5, 6]. Since their discovery, considerable efforts have been underway to assess
and quantify hiPSC-CM contractile function and to address the developmental state and phys-
iological maturity of the hiPSC-CM[7, 8, 9, 10].
The central measure of the physiologic function of a cardiac myocyte, and the essential pur-
pose of the cell, is force production. To date, several groups have implemented assays to mea-
sure force production of hiPSC-CMs, either as a syncytium[11, 12] or population of cells on a
thin film[13], or as single cells using micropost arrays[14] or, most recently, by using traction
force microscopy[15]. Force production is an important quantitative index of cardiac myocyte
maturity. It has been shown that human fetal cardiac myofibrils produce less force than adult
cardiac myofibrils, and that this increases over time in human development[16]. Furthermore,
isometric force in skinned myocytes from mice and sheep increase as gestational age increases
[17, 18]. Quantitative assessment of hiPSC-CMs during culture is, therefore, important to
ascertain as a key functional benchmark for maturation. In this study, we examine the impor-
tant question of whether increased age (length of differentiation) of hiPSC-CMs can improve
maturation.
We further hypothesized that hiPSC culture media composition is another critical factor in
guiding hiPSC-CM functional (force) maturation. It is well known that the physiologic extra-
cellular calcium concentration in mammalian interstitial spaces is between 1.5–2.0 mM[19],
providing a strong electrochemical gradient opposite a much smaller intracellular calcium
concentration in heart muscle[20, 21]. However, the calcium concentration in RPMI, which is
the basal media used in differentiation and growth of hiPSC-CMs used in several well-cited
protocols[2, 3], is sub-physiological at 0.42 mM[22]. Numerous groups have shown that extra-
cellular calcium and calcium signaling play a significant role in cardiac development, especially
in cardiac myocyte hypertrophy[23, 24]. With this information, we hypothesized that a physio-
logical extracellular calcium concentration in the culture media is necessary to further pro-
mote maturation of force production in hiPSC-CMs.
Intimately related to the myocyte’s ability to produce force is its morphology, including
total cell area, length and width. The use of micropattern printing to design and manipulate
the shape of neonatal ventricular cardiac myocytes shows a range of aspect ratios that result in
maximal force production, presumably by improved sarcomere and myofibril alignment[25,
26]. Recent studies in hiPSC-CMs demonstrate increased force in longer cells compared to
shorter ones[27]. Investigations of the relationship between cell size and force is important, as
cardiac myocyte size changes dramatically during cardiac development with the transition
from immature to mature cardiac myocyte, involving a significant increase in cell area[28].
Force production in both adult and fetal cardiac myocytes is known to be highly dependent
upon the load against which the cell is contracting. This includes the stiffness of the immediate
microenvironment[29]. Alterations in the myocyte microenvironment can have significant
effects in overall heart performance. For example, cardiac output is severely compromised in
cases where tissue stiffness changes drastically, as in fibrotic diseases of the heart[30]. The stiff-
ness of the human heart also changes during development in utero; however, the elastic modu-
lus of the developing myocardium is debated and varies markedly depending on the method
of measurement, as does measurement of the stiffness of other tissues[31]. To date, most
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studies report that the elastic modulus of the myocardium increases with age[32, 33]. Further-
more, the stiffness of myocardium is well known to be an important regulator of cardiac myo-
cyte function [34, 35, 36]. Thus, we hypothesized that the ability to produce force against
varying levels of stiffness is an important marker of human heart muscle physiologic maturity.
Therefore, in the present study, we investigated the functional maturation status of
hiPSC-CMs using single cell microprinting and traction force microscopy to measure force
production of isolated myocytes. We examined force in the context of several physiologically
relevant environmental parameters: first, we tested hiPSC-CMs contractile maturation by
comparing them to neonatal rat ventricular myocytes (NRVMs), with a focus on cell morphol-
ogy and geometry. Then, we measured force in response to substrates of varying stiffness.
Finally, we tested hiPSC-CM development after being cultured in varied physiologic extracel-
lular calcium conditions.
Results
HiPSC-CMs align and contract along a single axis
Human iPSC-CMs were transferred to polyacrylamide (PAA) gels that had been micropat-
terned with laminin rectangles with an area of 2000 μm2, which is larger than the expected
area based on previous measurements of hiPSC-CMs[6], and an aspect ratio of 7:1, which has
been reported as an ideal aspect ratio for NRVM force production[19]. This allowed individual
hiPSC-CMs to adhere to the substrate and occupy an area of up to 2000 μm2, allowing them to
take on their preferred size and geometry. Here, hiPSC-CMs formed an elongated geometry
aligned along the direction of the long axis of the patterned area (Fig 1A). Most hiPSC-CMs
formed geometries with an area smaller than 2000 μm2and an aspect ratio slightly smaller than
7:1 (Fig 1F).
Although hiPSC-CMs grown in 2-dimensional culture beat synchronously, isolated single
cells are heterogeneous and frequently do not beat at the same rate. Thus, patterned single
hiPSC-CMs were paced via field stimulator at 0.5 Hz and 35 mV. Pacing at 0.5 Hz, a rate fre-
quently used in experiments on isolated adult myocytes[37], allowed the cells to completely
return to baseline between contractions, which is important in defining the parameters of con-
traction. Paced myocytes contracted along their long axes, creating visible deformations in the
fluorescent bead-containing substrate (S1 Movie). Particle image velocimetry analysis showed
greatest substrate displacement towards the ends of the hiPSC-CMs, as well as in areas sur-
rounding the ends of the cells (Fig 1B). Traction force analysis showed that the largest traction
stress was developed in the substrate at these same locations (Fig 1C).
Averaged contractions fitted with a smoothed spline curve showed a force development
curve resembling that of adult cardiac myocytes (Fig 1D and 1E)[37, 38]. HiPSC-CM calcu-
lated maximum force measurements were on the order of 10−8 N, which is in line with mea-
surements previously reported by others[21]. The high resolution of the fluorescent images
necessary for accurate quantification of traction vectors allowed us to accurately capture peak
and return to baseline position of contracting hiPSC-CMs, as seen in Fig 1D. To further vali-
date our measurements, force trace ensembles of four contractions demonstrated a well-
defined and well-resolved contractile cycle (Fig 1E) consistent with single trace data (Fig 1D).
Heterogeneous cell geometry affects contractility
Differentiation protocols can result in the development of a heterogeneous population of car-
diac myocytes, as evidenced by varied electrophysiological parameters[39], calcium handling
[40] and gene expression profiles[40]. To address this, we sought to examine the potential
effects of geometric heterogeneity on physiologic force production. Micropatterned PAA
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constructs were designed as a rectangle with a 7:1 aspect ratio and a 2000 μm2 surface area.
HiPSC-CMs that have been cultured on the constructs are able to occupy an area of up to
2000 μm2, in their preferred aspect ratio, which ranged from 4:1 to as long as 10:1, with a mean
of 6.6:1 (Fig 1F). Based on this outcome, we examined the effects of cell geometry on contrac-
tility. We first measured total force production of d90 hiPSC-CMs on a 9.8 kPa substrate.
There was a significant positive correlation between cell size and total force produced (Fig 2A,
R2 = 0.21, P = 0.02). However, we found no correlation between long axis (length), short axis
(width), or aspect ratio and force (Fig 2B–2D). Based on these findings, for the remainder of
this paper we report total force, as well as force per unit area, which we refer to here as normal-
ized force.
Development of hiPSC-CMs under prolonged culture conditions
It is widely accepted that hiPSC-CMs phenotypically resemble immature cardiac myocytes
and, depending on the studied characteristics, resemble embryonic cardiac myocytes[41], fetal
cardiac myocytes[8, 16] or neonatal cardiac myocytes[13]. Furthermore, it has been hypothe-
sized that with increased culture time, a more mature phenotype can be obtained. Accordingly,
we examined TFM-based force production of hiPSC-CMs after 14 days, 30 days, or 90 days in
culture and compared to NRVMs.
At d14, hiPSC-CMs produce small but detectable amounts of force, whereas d30 cells pro-
duced significantly more total force and normalized force (one-way ANOVA P < 0.0001) (Fig
3A–3C). At d90, single hiPSC-CMs produced more total force than at d30. However, as they
were also larger, normalized force was not significantly different (Fig 3D). However, d90 cells
produced significantly more total force (P < 0.0001) and normalized force (P< 0.0001) than
d14 cells. D90 cells were significantly larger than d14 cells (P = 0.01). NRVMs showed similar
cell size and total force produced compared to d90 hiPSC-CMs; however, they had signifi-
cantly higher normalized force (P< 0.05).
Effects of substrate mechanics on contractility
Cardiac myocyte work adapts significantly during development[42]. Furthermore, cardiac
myocytes produce different amounts of traction force in response to altered mechanical envi-
ronments[15, 43]. To investigate whether this holds true for hiPSC-CMs, we cultured
hiPSC-CMs for 30 days under standard growth conditions (see Methods), then transferred iso-
lated hiPSC-CMs to PAA gels with a defined modulus of 3.1, 9.8, or 13.5 kPa. HiPSC-CMs had
decreased total force (One-way ANOVA, P< 0.0001) (Fig 4A) and normalized force (One-
way ANOVA P < 0.0001) (Fig 4C) as a function of increased substrate stiffness. HiPSC-CMs
on the 3.1 kPa modulus substrate produced significantly more force than on 9.8 or 13.5 kPa
(Fig 4A and 4C).
Cell area was not significantly different between conditions, indicating the range of sub-
strate stiffness tested was not sufficient to induce changes in cell spreading, and that cell
spreading was not the cause of differential force production (Fig 4B). At a substrate modulus
higher than 13.5 kPa, bead displacement was very small, resulting in a poor signal-to-noise
Fig 1. HiPSC-CMs and measurement of force by TFM. A. Representative cell, 30 days post-differentiation on a 9.8 kPa substrate. B.
Heat map showing magnitudes of deformation strain of the substrate under the representative cell. C. Heat map showing magnitudes
of stress of the representative cell calculated from strain of the substrate. D. Total force of a single cell over time with respect to
baseline at the point t = 0 seconds, over four contractions paced at 0.5 Hz, fitted with a smoothed spline curve. E. Total force of a
single cell over time, average of four contractions, fitted with a smoothed spline curve. F. Histograms showing distribution of cell
geometries.
https://doi.org/10.1371/journal.pone.0194909.g001
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ratio (data not shown). We also calculated strain energy generated by each cell during a full
contraction and found a decrease in strain energy with increasing stiffness. This correlated to
decreased force production, with cells on a substrate with a modulus of 3.1 kPa substrates gen-
erating significantly more energy than those on substrates with a modulus of 9.8 or 13.5 kPa
substrates (One-way ANOVA P< 0.0001).
Effects of culture media extracellular calcium content on hiPSC-CM
development
From well-cited protocols[12], the hiPSC-CM growth media contains sub-physiological levels
of calcium (~0.42 mM), whereas physiologic extracellular calcium concentrations are much
higher, ranging from 1.3 mM[44] to 2.0 mM[37, 45, 46]. To examine the effects of long term
media calcium concentrations on hiPSC-CM function, we cultured hiPSC-CMs in growth
media that had been supplemented with CaCl up to 1.8 mM Ca2+, beginning on the day that
they began spontaneously contracting (d7), and continuously until they were tested (d30).
They were all assayed in standard growth medium (Ca2+ concentration 0.4 mM). HiPSC-CMs
developing in media with physiologic calcium levels produced greater total force than cells
grown in standard growth medium, when assayed in standard growth medium (Ca2+
Fig 2. Effects of single cell d90 hiPSC-CM morphology on force production. A. Peak force versus cell area, R2 = 0.21, P<0.03, n = 24. B.
Peak force versus long axis (axis of contraction). C. Peak force versus short axis (perpendicular to axis of contraction). D. Peak force versus
aspect ratio (long axis/short axis).
https://doi.org/10.1371/journal.pone.0194909.g002
Traction force microscopy in hiPSC-derived cardiac myocytes
PLOS ONE | https://doi.org/10.1371/journal.pone.0194909 April 4, 2018 6 / 17
concentration 0.4 mM) on a 9.8 kPa substrate (P = 0.0073) (Fig 5A). Additionally, these
hiPSC-CMs were significantly larger (P = 0.0004) (Fig 5B). However, normalized force was
not significantly different between the two groups (p = 0.75) (Fig 5C).
In order to examine the mechanism whereby the increased extracellular calcium levels in
the culture media contribute to altered morphology and contractility, we measured calci-
neurin/NFAT effector activity by quantifying Rcan1.4 mRNA, which is directly influenced by
the calcineurin/NFAT pathway[47]. We found a significant 1.74-fold increase in Rcan1.4 in
d30 hiPSC-CMs that had been cultured in 1.8 mM Ca2+ containing media compared to the
standard 0.4 mM Ca2+ media composition (Fig 5D, P = 0.02).
Discussion
Human induced pluripotent stem cell-derived cardiac myocytes are an attractive model system
for experimental therapeutic discovery and as a potential cell/tissue source for regenerative
Fig 3. Effects of length of hiPSC differentiation on force production. Data shown as mean ± SEM. A. Representative hiPSC-CMs from day 14, day
30, and day 90 post-differentiation, and representative NRVM on substrate with modulus 9.8 kPa. B. Total force versus length of differentiation
(mean = 0.012 ± 0.001 μN, n = 17; 0.083 ± 0.013 μN, n = 15; 0.103 ± 0.011 μN, n = 24; 0.113 ± 0.016 μN, n = 12). C. Cell area versus length of
differentiation (mean = 605.7 ± 47.1 μm2, 702.3 ± 63.2 μm2, 898.2 ± 64.4 μm2, 741.9 ± 61.4 μm2). D. Normalized force versus length of differentiation
in culture (mean = 2.12 ± 0.23 mN/mm2 x 10−5, 13.0 ± 2.14 mN/mm2 x 10−5, 11.4 ± 1.4 mN/mm2 x 10−5, 15.3 ± 1.5 mN/mm2 x 10−5).
https://doi.org/10.1371/journal.pone.0194909.g003
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therapy in diseased hearts. However, a significant obstacle to realizing this potential is the
physiologic immaturity of hiPSC-CMs relative to adult cardiac myocytes. In this study, we uti-
lized single cell micropatterning with traction force microscopy for quantitative assessment
and investigation of absolute force production in isolated single hiPSC-CMs. Relative to other
methods of assaying cardiac myocyte contractility, single-cell traction force microscopy elimi-
nates potential confounding effects of neighboring cells, including myocytes and fibroblasts.
We report single cell hiPSC-CM peak contractile force in a range of 10−10 to 10−9 N, which is
comparable to other groups[27], although lower than some other studies[15]. This is likely due
to the regularization factor we used in the stress calculation, which has been shown to reduce
noise, but can also result in lower calculated overall stress values[48, 49].
Our study has several main new findings. Using microfabrication techniques to guide
hiPSC-CM area and aspect ratio, in adopting a rectangular shape with a single contractile axis
force vector, shows that force production correlates with overall cell area but not length, width,
Fig 4. Effects of substrate stiffness on d30 hiPSC-CM force production. Data shown as mean ± SEM. A. Total force versus substrate
elastic modulus (mean = 0.236 ± 0.02 μN, n = 21; 0.083 ± 0.01 μN, n = 15; 0.075 ± 0.01 μN, n = 22). B. Area versus substrate elastic modulus
(mean = 754.9 ± 31.5 μm2, 702.3 ± 63.2 μm2, 851.6 ± 43.7 μm2). C. Normalized force versus substrate elastic modulus (mean = 32.4 ± 3.5
mN/mm2 x 10−5, 13.0 ± 2.1 mN/mm2 x 10−5, 9.1 ± 1.0 mN/mm2 x 10−5). D. Strain energy versus substrate elastic modulus
(mean = 29.7 ± 4.3 fJ, 5.5 ± 1.7 fJ, 3.1 ± 0.6 fJ).
https://doi.org/10.1371/journal.pone.0194909.g004
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or aspect ratio. This led us to normalize all force measurements to cell area in order to obtain a
more accurate representation of cellular contractile performance, termed here as normalized
force, which is a different value than calculated stress. While aspect ratio did not significantly
correlate here to total force, aspect ratios were distributed normally around with a mean
between 6:1–7:1, which is very close to the aspect ratio that other groups have determined for
hiPSC-CMs and NRVMs to produce maximal force[25, 27] These results, although initially
appearing contradictory to other published studies[21], suggest that when hiPSC-CMs are
allowed to adopt a physiologically relevant geometry, they prefer to assume an optimal aspect
ratio for maximal force production in that individual cell.
Our data further demonstrates that hiPSC-CMs progress in terms of force output similarly
to the natural embryonic development of cardiac myocytes, wherein normalized force
increases as myocytes mature in vivo[16, 17]. Results show that hiPSC-CM normalized force
increases as a function of time in culture, which is in line with results from other research
groups[15]. Analysis of single hiPSC-CMs, compared to neonatal rat ventricular myocytes
Fig 5. Effects of calcium concentration in growth media on d30 hiPSC-CM force production on a substrate with modulus 9.8 kPa. Data
shown as mean ± SEM. A. Total force versus calcium concentration (mean = 0.083 ± 0.013 μN, n = 15; 0.147 ± 0.02 μN, n = 14). B. Cell area
versus calcium concentration (mean = 702.3 ± 63.2 μm2, 1130.3 ± 86.2 μm2). C. Normalized force versus calcium concentration
(mean = 13.0 ± 2.14 mN/mm2 x 10−5, 14.0 ± 2.0 mN/mm2 x 10−5). D. Rcan1.4 mRNA fold change (low Ca2+ group mean = 1.00 ± 0.29,
n = 8; physiological Ca2+ mean, 1.74 ± 0.29, n = 7)(P = 0.02).
https://doi.org/10.1371/journal.pone.0194909.g005
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under identical assay conditions, show that hiPSC-CMs produce comparable total force as
NRVMs. These results corroborate previous findings from our lab that hiPSC-CMs cultured
for prolonged periods of time begin to express some adult specific isoforms of contractile pro-
teins, such as cTnI, although still reflecting an immature expression profile compared to the
adult myocardium[9]. While instructive, these results also show that it is not yet been possible
to achieve physiologic maturation in terms of force output approaching that of adult cardiac
myocytes.
We discovered that ionic content of media for long-term hiPSC-CM culture has important
outcomes in terms of cellular maturation and force output. The effects of varied extracellular
calcium on the developing heart has been studied recently[25, 26], with evidence that cells
with sub-physiological calcium influx are smaller than those with normal calcium gradients
and signaling. With hiPSC-CMs in vitro, a unique opportunity is present to track force devel-
opment over time while modifying extracellular calcium levels directly. Data show increases in
hiPSC-CMs total force after being cultured in physiologic calcium levels (1.8 mM) compared
to the standard RPMI calcium levels (0.4 mM) employed by several groups, even when assayed
in standard 0.4 mM media. All other hiPSC-CMs in this paper were cultured in standard
RPMI with standard concentrations.
This is important because calcium signaling is crucial for cardiac myocytes in terms of exci-
tation-contraction coupling[43, 50], as well as signaling through calcium binding proteins,
such as calmodulin[51] and calcineurin[52].The increase in Rcan1.4 that we observed in
hiPSC-CMs treated with physiological calcium concentrations supports the possibility that the
physiologic changes force observed are mechanistically linked to enhanced calcineurin/NFAT
signaling. We cannot, however, exclude the potential for activation of other maturation signal-
ing pathways initiated by the two-week culturing of the hiPSC-CMs in physiological extracel-
lular Ca2+ conditions. Collectively, this is evidence that differentiation and development
protocols that attempt to recapitulate embryonic development should take into consideration
the concentration of calcium in the culture media.
Our data provide evidence of an inverse relationship between peak force and substrate stiff-
ness. This should be a significant consideration for ongoing and future studies attempting to
translate hiPSC-CMs for regenerative therapies for the diseased myocardium in vivo. Because
the stiffness of the human heart increases during development, and fetal myocardium is signif-
icantly softer than adult myocardium[26, 27], the ability of an hiPSC-CM to produce force
against soft versus stiff substrates may point to the developmental age of the cell. We utilized
here three moduli that are in line with the reported range that a cardiac myocyte encounters as
the heart develops from an embryonic state to adult[27]. Data show that both total force and
normalized force decrease as substrate modulus increases from 3.1 kPa to 9.8 kPa—13.5 kPa,
in agreement with a recent report[27]. These findings are in contrast to an earlier study[15];
however, it is difficult to directly compare findings due to the high variability of force values in
that earlier work.
The negative correlation between modulus and force development is consistent with the
idea that hiPSC-CMs represent an immature state, preferring to contract against a softer sub-
strate. Immature cardiac myocytes, to some degree, lack the cellular machinery to adequately
transmit force to their environment[53]. It has also been shown that alterations in the proteins
connecting the cytoskeleton to the extracellular makeup affect the traction of cells on stiffer
substrates[54], and that immature cardiac myocytes have incompletely developed dystrophin-
glycoprotein complexes[25]. Thus, we would expect immature cardiac myocytes to produce
force less efficiently against a stiffer substrate, as shown here for hiPSC-CMs.
Finally, we elucidate strain energy applied by hiPSC-CMs to the surrounding environment.
Strain energy characterizes the work done by the cell on the underlying substrate, which is
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fundamental to the force output of contractile cells, including hiPSC-CMs. It has been shown
that fibroblasts generate similar amounts of strain energy on substrates of different stiffness
[55]. However, as shown here, hiPSC-CMs generate less strain energy in the deformation of
stiffer substrates. We posit that hiPSC-CMs, due to their immaturity, are better able to produce
force against a substrate that more closely mimics the stiffness of an embryonic heart than that
of an adult or fibrotic heart. We speculate that further understanding of strain energy in
hiPSC-CMs may help decipher the basis of the difficulties encountered by groups attempting
to transplant immature hiPSC-CMs in stiff, diseased adult myocardium[4].
Taken together, these new data show that the functionality of hiPSC-CMs, as determined by
their ability to produce force against a substrate via single cell TFM, is a valuable quantitative
functional marker that closely resembles that of an immature cardiac myocyte. Specifically, in
terms of the impact of geometry on hiPSC-CM contractility, total normalized force production
by single myocyte TFM is similar to that of neonatal rat cardiac myocytes. As hiPSC-CMs per-
form more optimally working on less stiff substrates, we report hiPSC-CMs function is compa-
rable to neonatal cardiac myocytes. In addition, this study shows the important role of length of
differentiation in culture and the effects of extracellular calcium concentration in the culture
media on the maturation of hiPSC-CMs. Ultimately, quantitative analysis of hiPSC-CM con-
tractile performance as done here via traction force microscopy and using micropatterned plat-
forms with substrates of differing stiffness in the developmental range of heart tissue will be
critical toward optimization of culture conditions and cell environment, including matrices, to
advance the maturation state of hiPSC-CM toward human adult myocardium.
Experimental procedures
Culture and differentiation of human iPSC-derived cardiac myocytes
Human iPSC line DF 19-9-11T, which was derived from healthy donor fibroblasts using a vec-
tor-free episomal induction method[56], was graciously provided to us by the laboratory of
Dr. Timothy Kamp at the University of Wisconsin-Madison. HiPSCs were cultured according
to the protocol outlined in that paper; briefly, cells were grown in TESR-E8 media (Stemcell,
Vancouver, CA), on Matrigel-coated (Corning, Corning, NY) 35 mm 6 well plates, and pas-
saged every 4 days via EDTA with a dilution factor of 1:12.
HiPSCs were differentiated according using a small molecule Wnt/GSK3 inhibition proto-
col2. Briefly, hiPSCs were cultured to approximately 90% confluency, then treated with a GSK3
inhibitor, CHIR99021 (Stemgent, Cambridge, MA) in RPMI supplemented with B-27 minus
insulin (Thermo Fisher, Waltham, MA) and Matrigel, for 24 hours. Media was replaced for 48
hours. Cells were treated with IWP-4 (Stemgent, Cambridge, MA) in RPMI with HEPES with
B-27 minus insulin for 48 hours, and media was replaced every 48 hours until cells began to
beat spontaneously, at which point they were grown in RPMI with HEPES supplemented with
insulin-replete B-27, with a Ca2+ concentration 0.4 mM (standard RPMI concentration).
Media was changed every 2–3 days until ready for assays. Higher-calcium (physiological)
media was prepared by supplement RPMI + B27 growth media to 1.8 mM Ca2+ using 1M
CaCl, and then stirred to dissolve any precipitations that form. Cells grown in physiological
calcium media had media changed every 1–2 days, as these cells produce acidic media more
rapidly. Each condition tested in this paper used data pooled from hiPSC-CMs from 3–4 inde-
pendent differentiations.
Isolation and culture of neonatal rat ventricular myocytes
All methods for handling laboratory animals were approved by the Institutional Animal Care
and Use Committee at the University of Minnesota. One-day old Sprague Dawley rat pups
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were sacrificed via decapitation and hearts excised through the chest. Cardiac myocytes were
isolated using sequential trypsin and collagenase treatments according to the protocol pro-
vided with the Worthington Neonatal Cardiomyocyte Isolation System (Worthington Bio-
chemical, Lakewood, NJ). NRVMs were plated directly onto patterned polyacrylamide
constructs at a density of 100,000 cells per well and cultured in DMEM + 4% FBS. Media was
changed after 24 hours, and cells were allowed to continue to adhere for 48 more hours until
assaying. NRVMs were treated the same way as hiPSC-CMs during the assay procedure.
Micropatterning of polyacrylamide constructs
Micropatterning stamps were created according to protocols outline by Wang et al[57]. Briefly,
photomasks were designed in AutoCAD (AutoDesk, Mill Valley, CA) and printed by Fineline
Imagine (Colorado Springs, CO). Single cell shapes were placed far enough apart to ensure
contraction of one cell would not affect substrate deformation of neighboring cells. Stamp
masters were created using photolithography by applying photomasks to silicon wafers coated
with photoresist and exposing to light. Stamps were created by curing polydimethylsiloxane
(PDMS) (Dow Corning Sylgard 184, Ellsworth Adhesives) on the patterned silicon master (for
patterned stamp) or on an unpatterned silanized silicon wafer (for blank stamps). Both pat-
terned and unpatterned stamps were made new each time they were used. Stamps were coated
and stamped according to the stamp-off protocol laid out by Desai et al[58]. Briefly, blank
stamps were coated with laminin (50 μg/ml in molecular biology grad water) and incubated
for 60 minutes, then dried and inverted onto patterned stamps which have been UV-activated.
Blank stamps were immediately peeled off and placed onto 15 mm coverslips which had been
plasma-activated by running through a blue flame. Cover slips were then ready for use with
gels.
Polyacrylamide gel construction
Polyacrylamide gels were made using ratios of Acrylamide to N,N’-methylenebisacrylamide
according to Tse et al[59] and then actual gel stiffness was measured using uniaxial stress test-
ing (S1 Table). Ahead of time, 25 mm glass coverslips were UV treated, then treated with
3-aminopropyltriethoxysilane for 3 minutes, and rinsed with ethanol. Polyacrylamide was
made with 1x phosphate-buffered saline, and 0.2 μm red FluoSpheres fluorescent beads
(Thermo Fisher, Waltham, MA) were mixed into the unpolymerized acrylamide solution at a
concentration of 0.005% (diluted 1:200). The solution was degassed for 15 minutes, and to the
unpolymerized solution was added tetramethylethylenediamine (final dilution 1:1500), and
the solution was brought to a pH of 7 via HCl. Ammonium persulfate (final concentration
0.017% w/v) and N-hydroxysuccinimide ester (final concentration 0.0083 mg/ml) were added
to solution. 15 μl of solution were quickly pipetted onto APS-treated coverslips. Laminin-
coated coverslips were inverted onto the solution and allowed to polymerize at room tempera-
ture for 60 minutes. Top coverslips were removed from the polymerized gels, and gels were
incubated in 4% BSA at 37˚ for 45 minutes, then rinsed 3 times with 1x PBS.
HiPSCs were dissociated in Accutase (Thermo Fisher, Waltham, MA) for 20 minutes, then
resuspended in warm RPMI + B27 and replated onto polyacrylamide gels at 100,000 cells per
well. Cells adhered overnight, then media was changed the following morning. Cells were
allowed to adhere for two more days, then assayed on day 3 after plating.
Traction force microscopy and analysis
Experiments were performed on an Olympus X81 Inverted Microscope using a 40x UPLSA-
PO40X2, NA 0.95 objective in an environmental control chamber at 37˚C. Images were
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acquired using MetaMorph software (Molecular Devices, Sunnyvale, CA) at a rate of 3.5
frames per second. Cells were paced at 0.5 Hz with a 35 mV square pulse using a MyoPacer
field stimulator (IonOptix, Westwood, MA) in RPMI + B27 with HEPES. Cells were paced for
3–5 minutes before recording, and data was recorded from each dish for no more than 30 min-
utes to avoid recording from dying cells. Cells were given fresh media 60 minutes before data
acquisition.
Images were analyzed using ImageJ code developed by Tseng et al[60, 61]. Stacks of images
of the cell and fluorescent beads before and during contraction were oriented vertically and
cropped to an area of 64.4 μm wide by 128.8 μm tall before analysis. Particle image velocimetry
using iterative interrogation windows of 128-64-32 pixel width was completed between the
matched bead images from the same cell location at different time points. The noise-filtered
displacement field was used to calculate traction stresses with a Fourier transform traction
cytometry (FTTC) ImageJ plugin using the Fourier transform traction cytometry method[51].
A regularization factor of 1x10-9 was applied for improved accuracy, as described in Stricker
et al[50]. Stress vector magnitudes were integrated over the entire 64.4 μm by 128.8 μm area of
interest and reported as total force in μN. Normalized force was calculated by dividing total
force by the area of the cell and is reported in μN/μm2 x 10−5. Strain energy of the substrate






where T is the traction stress and u is the displacement.
Real-time PCR
Rcan1.4 primers were synthesized by Integrative DNA Technology (Coralville, IA) using the
primer sequences shown below. RNA was extracted from dissociated hiPSC-CMs using the
RNEasy Plus kit (Qiagen, Hilden, Germany) and quantified by NanoDrop spectrophotometry
(NanoDrop, Wilmington, DE). Next, cDNA libraries were generated using the Superscript
Vilo kit (Thermo Fisher, Waltham, MA) and quantitative real-time PCR was performed using
the Bio-Rad SYBR Green qPCR Master Mix Bio-Rad, Hercules, CA) on an Eppendorf Master-
cycler machine (Eppendorf, Hamburg, Germany). Analysis of expression and fold change was




All statistical analysis was performed using Prism software (GraphPad, San Diego, CA). Corre-
lation analysis was done by linear regression, and estimation of significant non-zero slopes was
determined. Significant differences between groups for all other experiments was estimated by
one-way ANOVA with a Tukey’s post hoc test. Significant differences in Fig 5 were estimated
with a Student’s T test. Spline plots in Fig 1 were created using Matlab (Mathworks, Natick,
MA).
Supporting information
S1 Movie. HiPSC-CM displacement of fluorescent beads in the hydrogel substrate.
(AVI)
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S1 Table. Measurements of hydrogel stiffness.
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